- Immunotherapy in Head and Neck Squamous Cell Cancer
-
Denaro N, Merlano MC
- KMID: 2439847
- Clin Exp Otorhinolaryngol.
- 2018 Dec;11(4):217-223.
- doi: 10.21053/ceo.2018.00150
Prognosis in relapsed metastatic head and neck squamous cell cancer (RM-HNSCC) is dismal. Platinum based chemotherapy in combination with Cetuximab is used in first-line setting, while no further validated options... -
- CITED
-
- Close
- SHARE
-
- Close
- Recent Advances in Cervical Cancer Vaccine Development
-
Ahn WS
- KMID: 1594549
- Korean J Obstet Gynecol.
- 2005 Jun;48(6):1377-1389.
Human papillomavirus infection is often transient and spontaneously reversible. High-risk human papillomavirus persistence is the major cause of cancerous transformation in several tissues. For prophylactic vaccines there is first clinical... -
- CITED
-
- Close
- SHARE
-
- Close
